Broadwater Capital’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1K Hold
2
﹤0.01% 202
2026
Q1
$1.16K Hold
2
﹤0.01% 202
2025
Q4
$1.16K Hold
2
﹤0.01% 202
2025
Q3
$970 Sell
2
-809
-100% -$377K ﹤0.01% 209
2025
Q2
$811K Buy
811
+809
+40,450% +$338K ﹤0.01% 212
2025
Q1
$995 Hold
2
﹤0.01% 208
2024
Q4
$1.04K Hold
2
﹤0.01% 217
2024
Q3
$1.24K Hold
2
﹤0.01% 221
2024
Q2
$1.11K Hold
2
﹤0.01% 222
2024
Q1
$1.16K Hold
2
﹤0.01% 217
2023
Q4
$1.06K Buy
+2
New +$968 ﹤0.01% 213

Other funds holding TMO

Broadwater Capital's TMO Position: Q2 2026 in Review

Broadwater Capital held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 2 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #202.

Broadwater Capital first reported a position in TMO in Q4 2023 and has held it in 11 quarters since. The position peaked at $811K in Q2 2025. 1,426 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Broadwater Capital held 2 shares of Thermo Fisher Scientific worth $1K as of Q2 2026.
  • Broadwater Capital left its Thermo Fisher Scientific share count unchanged in Q2 2026.
  • Thermo Fisher Scientific made up ﹤0.01% of Broadwater Capital's portfolio in Q2 2026, its #202 holding.
  • Broadwater Capital first reported a position in Thermo Fisher Scientific in Q4 2023 and has held it in 11 quarters since.
  • Broadwater Capital's Thermo Fisher Scientific position peaked at $811K in Q2 2025.
  • 1,426 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Broadwater Capital's 13F filing for Q2 2026, filed 24 Jul 2026.